BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16227983)

  • 1. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.
    D'Cruz LM; Klein L
    Nat Immunol; 2005 Nov; 6(11):1152-9. PubMed ID: 16227983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
    Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
    Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo.
    Schramm C; Huber S; Protschka M; Czochra P; Burg J; Schmitt E; Lohse AW; Galle PR; Blessing M
    Int Immunol; 2004 Sep; 16(9):1241-9. PubMed ID: 15249539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
    Carson BD; Ziegler SF
    Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
    Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
    Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y; Amarnath S; Chen W
    Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
    Pacholczyk R; Ignatowicz H; Kraj P; Ignatowicz L
    Immunity; 2006 Aug; 25(2):249-59. PubMed ID: 16879995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and function of CD25+CD4+ regulatory T cells.
    Fehérvari Z; Sakaguchi S
    Curr Opin Immunol; 2004 Apr; 16(2):203-8. PubMed ID: 15023414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3-dependent programme of regulatory T-cell differentiation.
    Gavin MA; Rasmussen JP; Fontenot JD; Vasta V; Manganiello VC; Beavo JA; Rudensky AY
    Nature; 2007 Feb; 445(7129):771-5. PubMed ID: 17220874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.